Insider Transactions in Q1 2023 at Signify Health, Inc. (SGFY)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 07
2023
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
5,660
-1.84%
|
$158,480
$28.37 P/Share
|
Feb 27
2023
|
Tim Gronniger Ch. Value-Based Sols. Off |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+20.96%
|
-
|
Feb 27
2023
|
Adam Mc Ananey General Counsel and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
52,102
+28.03%
|
-
|
Feb 27
2023
|
Steve Senneff Pres. Chief Fin. & Admin. Off. |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+21.99%
|
-
|
Feb 27
2023
|
David Pierre Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+29.68%
|
-
|
Feb 27
2023
|
Josh Builder Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+39.88%
|
-
|
Feb 27
2023
|
Marc D Rothman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
34,735
+32.86%
|
-
|
Feb 27
2023
|
Laurence Michael Orton Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,894
+29.07%
|
-
|
Feb 27
2023
|
Paymon Farazi Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
86,836
+26.79%
|
-
|
Feb 27
2023
|
Bradford Kyle Armbrester Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
295,242
+43.22%
|
-
|